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Lipoic acid (LA) is an essential cofactor of a-keto acid dehydrogenase complexes (KADHs) and the glycine cleavage
system. In Plasmodium, LA is attached to the KADHs by organelle-specific lipoylation pathways. Biosynthesis of LA
exclusively occurs in the apicoplast, comprising octanoyl-[acyl carrier protein]: protein N-octanoyltransferase (LipB)
and LA synthase. Salvage of LA is mitochondrial and scavenged LA is ligated to the KADHs by LA protein ligase 1
(LplA1). Both pathways are entirely independent, suggesting that both are likely to be essential for parasite survival.
However, disruption of the LipB gene did not negatively affect parasite growth despite a drastic loss of LA (.90%).
Surprisingly, the sole, apicoplast-located pyruvate dehydrogenase still showed lipoylation, suggesting that an
alternative lipoylation pathway exists in this organelle. We provide evidence that this residual lipoylation is
attributable to the dual targeted, functional lipoate protein ligase 2 (LplA2). Localisation studies show that LplA2 is
present in both mitochondrion and apicoplast suggesting redundancy between the lipoic acid protein ligases in the
erythrocytic stages of P. falciparum.
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Introduction
Lipoic acid (6,8-thioctic acid; LA) is an essential cofactor
that is covalently attached to the transacylase subunit (E2-
subunit) of a-keto acid dehydrogenase complexes (KADHs),
namely pyruvate dehydrogenase (PDH), a-keto glutarate
dehydrogenase (KGDH), and branched chain a-keto acid
dehydrogenase (BCDH) as well as the H-protein of the glycine
cleavage system (GCS) [1,2]. In eukaryotes, these multienzyme
complexes are generally found in the mitochondrion. Only
plants and plastid-containing organisms possess organelle-
speciﬁc PDH with the plastid PDH providing substrates for
fatty acid biosynthesis [3]. Therefore, mitochondrion and
plastid require the enzymatic machineries for the posttransla-
tional lipoylation of KADHs or H-protein [2–5].
LA is provided and ligated to the respective target proteins
by two distinct pathways. The cofactor can be synthesised by
almost all organisms using the LA biosynthesis pathway. This
requires octanoyl-acyl carrier protein (ACP) as a substrate (a
product of fatty acid biosynthesis) which is ligated to the apo-
E2-subunits or the apo-H-protein by octanoyl-[acyl carrier
protein]: protein N-octanoyltransferase (LipB) [6]. Subse-
quently, two sulphurs are introduced into position 6 and 8 of
the protein-bound octanoic acid, a reaction that is catalysed
by lipoic acid synthase (LipA) [7,8]. LA can also be acquired
through the salvage pathway. In mammals free, salvaged LA is
transferred to the E2-subunits of KADHs through two
enzymatic steps but in bacteria, fungi, and apicomplexan
parasites this reaction is catalysed by a single enzyme [6,9–12].
Scavenged LA in mammals is ﬁrst activated through an ATP-
dependent reaction catalysed by LA activating enzyme before
the activated form of LA is then attached to the E2-subunits
or the H-protein by LA transferase [9,10]. In contrast,
bacterial-type LA protein ligases (LplA) catalyse the activa-
tion and transfer of LA in a single enzymatic step [6].
LA metabolism in the malaria parasite Plasmodium falcipa-
rum and the related apicomplexan parasite Toxoplasma gondii
display an organelle-speciﬁc distribution of biosynthetic and
salvage pathways [11–15]. LA biosynthesis is exclusively found
in their plastid-like organelle, the apicoplast, whereas LA
salvage is conﬁned to their mitochondrion. It was shown that
both organelles contain members of the KADHs, which
require posttranslational lipoylation [16–18]. It is assumed
that these multienzyme complexes play pivotal roles in the
parasite’s metabolism and it is thought that both LA biosyn-
thesis and salvage are essential for parasite survival. This is
further supported by the ﬁndings of Crawford and colleagues
[13] showing that newly synthesised LA does not exit the
apicoplast and by Allary and colleagues [14] who showed that
radiolabelled LA is not utilised to lipoylate apicoplast PDH,
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subunits. These studies therefore provide evidence that the
organelles’ lipoylation machineries act independently and
inhibition of either one should have deleterious effects for
the parasites. Indeed proof of this concept is supported by
the lethal effect of the LA analogue 8-bromo-octanoic acid on
intraerythrocytic stages of P. falciparum and also T. gondii
[13,14]. In this study we have further tested this hypothesis by
disrupting the Plasmodium apicoplast targeted LipB gene,
which is part of the LA de novo biosynthesis pathway.
Surprisingly, the gene disruption is not deleterious for the
parasites suggesting that Plasmodium possesses alternative
routes for LA ligation in this organelle. Our results provide
evidence that a second LA protein ligase-like protein, LplA2
[13,14], can replace LipB function.
Results
Plasmodium falciparum Possesses Lipoylated KADH and H-
Protein
To verify that the protein bands recognised by an antibody
directed against protein-bound LA (anti-LA), which was used
in this study to detect lipoylated proteins in P. falciparum
(Figure 1, lane 4), Western blots of parasite extracts were also
analysed with antisera raised against P. falciparum H-protein,
BCDH-E2 and KGDH-E2 (Figure 1, lanes 1–3). The sizes of the
proteins detected by the anti-LA antibody correlated well
with those protein bands detected by the antibodies directed
against the three mitochondrial proteins. These results
corroborate the previously published suggestion that the
protein bands detected by the anti-LA antibody in fact
represent the mitochondrial KADHs. The 75 kDa band that
was detected by anti-LA was previously shown to correspond
to the PDH-E2-subunit [14].
The LipB Gene Can Be Disrupted
The gene encoding LipB was targeted using two different
constructs (see Materials and Methods) cloned into the P.
falciparum transfection plasmid pHH1. This plasmid confers
single cross over recombination resulting in a disruption of
the endogenous gene locus [19]. Both constructs lacked the
last 100 amino acids including a catalytically essential, highly
conserved cysteine residue at position 369 (Plasmodium LipB
numbering) which was shown to form a catalytic dyad with a
conserved lysine residue in position 307 (Plasmodium LipB
numbering) in the Mycobacterium tuberculosum LipB protein
[20]. Therefore it was assumed that the disruption of the
endogenous LipB gene locus should result in the generation
of a C-terminally truncated LipB protein unlikely to display
any enzymatic activity.
Independent transfections of both constructs were per-
formed and the genotype of the transfected parasite lines was
analysed by Southern blotting to verify the presence of the
transfected plasmid. All analysed parasite genotypes revealed
that the LipB gene locus had been targeted and the
independent transfectants were cloned by limiting dilution.
Two independent clones from separate transfections with
each construct were used for further analyses (Figure 2).
LipBKO1–1 and LipBKO1–2 describe the 3D7 derived
mutants and LipBKO2–1 and LipBKO2–2 describe the D10
derived mutants. Upon NdeI digestion of genomic DNA of all
four clones, the endogenous gene of 2.8 kb (Figure 2, lanes 1
and 2) is replaced by two bands of approximately 3.7 kb and
4.9 kb (Figure 2, lanes 3–6) diagnostic for the disruption of
the LipB gene locus.
Does the LipB Knockout Affect Parasite Growth?
Growth experiments performed according to Sanders et al.
[21] showed that the LipB disruption with either construct,
and regardless of parasite strain, resulted in a modestly
increased growth rate of the LipB mutants compared to both
parent lines (3D7 and D10) (Figure 3). Six days after the
experiment was started with highly synchronised, ring-stage
parasites, the parasitemia of the wild-type controls was
determined to be between 1.8% and 2% whereas the LipB
mutants consistently had a parasitemia between 4% and 5%.
This increased growth rate could be explained in several ways;
e.g., an accelerated cell cycle, the generation of a greater
Figure 1. Identification of Lipoylated Proteins in P. falciparum
P. falciparum protein extracts (15 lg) were separated on an SDS-PAGE
(4%–12%, Invitrogen) and blotted onto nitrocellulose as described in the
Materials and Methods section. The blots were analysed using four
different antibodies: (lane 1) rabbit anti-H-protein at 1:2,000 recognising
a 25 kDa band; (lane 2) rabbit anti-BCDH-E2 at 1:100 recognising a 50
kDa band; (lane 3) rat anti-KGDH-E2 at 1:5,000 recognising a 47 kDa
band; (lane 4) rabbit anti-lipoic acid at 1:500 recognising four major
protein bands corresponding to PDH-E2 (75 kDa, Allary et al. [14]), BCDH-
E2 (50 kDa), KGDH-E2 (47 kDa) and H-protein (25 kDa).
doi:10.1371/journal.ppat.0030189.g001
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Author Summary
Plasmodium falciparum is the causative agent of severe malaria. The
parasites possess two organelles that are integral to their
metabolism—the mitochondrion and the apicoplast, a remnant
plastid. Both organelles contain enzymes that depend on the
attachment of the cofactor lipoic acid for their catalytic activity.
These are the a-keto acid dehydrogenase complexes and the glycine
cleavage system (GCS). The pyruvate dehydrogenase (PDH) is solely
found in the apicoplast of the parasites whereas a-keto glutarate
and branched chain a-keto acid dehydrogenase as well as the GCS
are mitochondrial. Both organelles possess specific and independent
mechanisms that guarantee the posttranslational lipoylation of
these enzyme complexes. In this study we show that the apicoplast
located lipoic acid protein ligase, octanoyl-[acyl carrier protein]:
protein N-octanoyltransferase (LipB), is not essential for parasite
survival by disrupting the LipB gene locus. Despite a drastic loss of
total lipoic acid, the parasites progress through their intraerythro-
cytic development unperturbed although the apicoplast-located
PDH shows a reduced level of lipoylation. This phenotype is
attributable to the presence of the recently described lipoic acid
protein ligase 2, LplA2, which we show to be dually targeted to
mitochondrion and apicoplast.number of merozoites, or a more successful invasion rate by
the mutant parasites.
The ﬁrst point was addressed by following tightly
synchronised parasites through the 48 h developmental cycle.
Blood smears were taken every 8 h and the progression
through the cell cycle of the different parasite lines was
analysed microscopically (Figure 4). The experiment was
started with tightly synchronised ring-stage parasites of all six
parasite lines and this time point was set as 0 h. Eight hours
later, between 50% and 80% of the LipB mutants had
developed into trophozoites, whereas only 20% to 25% of
either D10 or 3D7 Plasmodium had progressed to this
developmental stage. Generally the 3D7 wild-type and the
3D7-based mutants showed a faster progression through their
intraerythrocytic development than the D10 wild-type and
mutant lines (Figure 4). Thirty two hours after the start of the
experiment almost all of the LipB mutant parasites had re-
infected fresh erythrocytes and had successfully progressed
through their life cycle, whereas 3D7 needed another 8 h to
reach this point and D10 needed even longer. In summary,
the data clearly show that all four LipBKO mutants (the two
selected 3D7-based KO1 clones and the two D10-based KO2
clones) progress through their intraerythrocytic cell cycle
faster (about 4 to 8 h) than the two wild-type lines, which
suggests that the disruption of the LipB gene locus in some
way affects parasite cell cycle control. Determining parasite
numbers at the beginning and the end of the parasites’ life
cycles revealed that the LipBKO schizonts generated, on
average, the same number of successfully infective merozoites
as wild-type parasites per life cycle.
Effect on Lipoic Acid Content
The LA content of wild-type and the LipB null mutants was
quantiﬁed by gas chromatography-mass spectrometry (GC-
MS). This revealed that all of the LipB null mutants showed a
drastic reduction in total LA content (Figure 5A; Table 1)
compared to the wild-type parasite lines. Both P. falciparum
3D7 and D10 contain approximately 40 nmol/10
8 cells of LA
whereas the LipB mutants only contain between 0.6 nmol/10
8
cells and 2.2 nmol/10
8 cells; a reduction of more than 90% of
total LA. In addition to the total LA in the cell, it was possible
to distinguish between oxidised and reduced protein-bound
LA; the ratio of which was only marginally affected by the
LipB disruption, varying between 1.2 and 4.5, with the
oxidised form of LA being predominant (Table 1).
Apart from changes in LA levels, the LipB disruption lead
to a 5-fold increase in myristate (C14:0) in the LipB mutants
(from 1.8 nmoles/10
8 cells to 9 nmoles/10
8 cells). This is
presumably the result of the increased availability of
octanoyl-ACP, which is no longer required for LA biosyn-
thesis and so can be further extended to C14 (Figure 5B).
Thus, the decreased requirement for LA biosynthesis because
of the lack of LipB function generates a surplus of longer
chain fatty acids, which can be used for instance for protein
modiﬁcations such as acylations and lipid biosynthesis. The
major overall ﬁnding of this part of the study was that the
LipB disruption leads to a drastic reduction of total LA in the
parasites without affecting parasite viability.
From these data it also can be deduced that the level of
lipoylation of PDH-E2 should be greatly reduced if not
ablated if LipB is the only protein that transfers the LA
cofactor to the multienzyme complex in the apicoplast. This
was qualitatively analysed by Western blotting using anti-LA
antibodies which shows that PDH-E2 lipoylation indeed
decreases signiﬁcantly but does not totally disappear (Figure
5C, compare lane 1 with lanes 2 and 3), suggesting an
alternative mechanism that allows for partial PDH-E2 lip-
oylation in the absence of LipB activity. The E2-subunits of
Figure 2. Southern Blot of P. falciparum LipB Mutants
Genomic DNA was isolated from wild-type (P. falciparum 3D7 and D10)
as well as four independent LipB mutant clones (KO1–1, KO1–2; KO2–1
and KO2–2). The DNA was digested with NdeI and separated on a 0.8%
agarose gel before blotting to nylon and probing with the LipB coding
region. The band shown in lanes 1 and 2 corresponds to the endogenous
LipB gene locus (2.8 kb). The 2.8 kb band disappears and is replaced by
two bands diagnostic for the disruption of the endogenous LipB locus
(3.7 kb and 4.9 kb) in all four cloned parasite lines (lanes 3–6).
doi:10.1371/journal.ppat.0030189.g002
Figure 3. Growth of LipB Mutants
Parasite growth was assessed over six days according to Sanders et al.
[21]. (A) 3D7 wild-type and KO1–1 and KO1–2; (B) D10 wild-type and
KO2–1 and KO2–2. The experiment was started with highly synchronised
ring-staged cultures which were monitored daily and diluted 5-fold every
48 h. For each determination of percentage parasitemia, the number of
infected erythrocytes per 1,000 erythrocytes was recorded. Means and
standard errors of three separate experiments are shown.
doi:10.1371/journal.ppat.0030189.g003
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Lipoic Acid Protein Ligases of Plasmodiumthe mitochondrial KADH also show a slight decrease of
lipoylation, suggesting that the knockout of the apicoplast
LipB might also affect the modiﬁcation of the mitochondrial
enzyme complexes.
Effect on Fatty Acid Biosynthesis and Susceptibility
Towards Pro-Oxidants
Apicoplast PDH is thought to be the source of acetyl-CoA
for type II fatty acid biosynthesis in apicomplexan parasites
[22] and the drastic reduction of LA in the parasites led to the
conclusion that the activity of PDH-E2 might be negatively
affected and as a consequence the provision of substrates for
de novo fatty acid biosynthesis might be reduced. This
hypothesis was tested by investigating the sensitivity of the
mutants to triclosan, an inhibitor of FabI; one of the enzymes
involved in fatty acid elongation in P. falciparum and
previously validated as a drug target [23]. However, our data
show that the LipB disruption does not have any effect on the
susceptibility of mutant parasites towards triclosan, possibly
suggesting that the residual lipoylation of PDH-E2 is
sufﬁcient to provide enough acetyl-CoA to sustain fatty acid
biosynthesis at wild type level (Figure 6A).
Another hypothesis requiring investigation was the sugges-
tion that LA might act as a principal antioxidant in the
organelles of Plasmodium. In order to further substantiate this,
the IC50 for two pro-oxidants were determined; wild-type and
LipB null mutants showed no differential susceptibility
towards tert-butylhydroperoxide and N-methylphenazonium
methosulfate, respectively (Figure 6B and 6C).
Can LplA2 Compensate for the Loss of LipB?
It was shown previously that Plasmodium possess a second
functional LplA-like protein, which compensated growth of a
bacterial strain lacking both LipB and LplA, but which was
unable to compensate growth of a LipB deﬁcient bacterial
line in a previous study [14]. It was suggested that LplA2 is not
able to replace LipB function in the bacteria because of their
distinct substrate speciﬁcities. In this study we expressed
three different expression constructs in LipB and LipB/LplA
deﬁcient Escherichia coli lines, respectively [24,25]. The con-
structs used here were full length at their C-termini and
included a C-terminal tag as opposed to the construct
expressed in the previous study. The N-terminus of the three
constructs differed because the deduced amino acid sequence
has an N-terminal extension of 28 amino acids when
compared to E. coli LplA which potentially encodes an N-
terminal targeting sequence. It is possible that such N-
terminal targeting sequences interfere with efﬁcient expres-
sion or function of the heterologous parasite protein in the
prokaryotic expression system and therefore it was decided to
analyse three different expression constructs of LplA2 (as
outlined in the Materials and Methods section) in the
complementation assay. In our hands all three constructs
complemented the growth of the LipB deﬁcient bacteria
(Figure 7A), suggesting that the protein can replace LipB
function. These data are in contrast to those obtained by [14]
but might be explained by differences in expression plasmids
and constructs used in the two different studies. This does not
exclude the possibility that LplA1 and LplA2 proteins have
differential, albeit somewhat overlapping, substrate speciﬁc-
ities or activity proﬁles through the developmental cycle of P.
falciparum. The LplA2 constructs also compensated for the
growth defect of TM136, a bacterial line deﬁcient in LplA and
LipB (Figure 7B) [25].
Localisation of LplA2
A clear prediction of LplA29s localisation is not possible
and therefore this was analysed by expressing a C-terminally
green ﬂuorescent protein (GFP)-tagged full-length LplA2
protein in the erythrocytic stages of P. falciparum. The results
suggest that LplA2-GFP is targeted to two distinct organ-
elles—one of which is clearly the mitochondrion as LplA2-
GFP colocalises with Mitotracker (Figure 8). Given the close
association of the second organelle to the mitochondrion we
suggest that this is likely to be the apicoplast. This was
corroborated by immunoﬂuorescence studies using anti-
bodies raised against LplA2 and apicoplast lipoamide
dehydrogenase (aLipDH; aE3; P. J. McMillan and S. Mu ¨ller,
unpublished data). The results show that in some parasites
both proteins clearly colocalise, supporting its localisation in
the apicoplast (Figure 9). However, the localisation of LplA2
is not that straightforward. In some parasites we clearly
observe colocalisation with either Mitotracker or, in the
immunoﬂuorescence study, with aLipDH, whereas in others
the staining is present in both organelles. Analysing the
distribution in 46 distinct parasites from the immunoﬂuor-
escent experiment resulted in the following distribution:
19.6% of LplA2 colocalised with aLipDH and thus is
apicoplast located; 53% were found in an organelle distinct
to the apicoplast but likely to be the mitochondrion, and 28
% showed staining of both organelles. Similarly, the LplA2-
GFP expressing parasites were analysed (50 parasites) and
15% of staining was likely to be apicoplast (distinct from the
mitochondrion stained with Mitotracker), 68% were found to
have LplA2-GFP in the mitochondrion and 18% showed
staining in both organelles. These data indicate that LplA2 is
dually targeted within the parasites albeit the precise
mechanisms governing this distribution need to be analysed
in future studies.
Overall, the functionality and localisation studies of LplA2
strongly support our hypothesis that LplA2 indeed compen-
sates for the loss of LipB function, although it appears that its
ability to utilise the octanoyl-ACP substrate provided by fatty
acid biosynthesis might not be as efﬁcient as it is by LipB
given the extensive loss of protein-bound LA and the
reduction of lipoylation of PDH-E2.
Figure 4. Progression of Wild-Type and LipBKO Mutants through Intraerythrocytic Cell Cycle
Progression through the intraerythrocytic developmental cycle was assessed by analysing Giemsa stained thin-smears of highly synchronised cultures
that were taken every 8 h for a period of 48 h. The experiments were started with ring-stage parasites (rings) and the development through one
intraerythrocytic life cycle was followed by determining the occurrence of rings, trophozoites, and schizonts by light microscopy. The images represent
typical appearance of these parasite stages. The numbers show the percentage of rings, trophozoites, and schizonts counted at the respective time
point. The progression of the LipB mutants (3D7-based, panel A and D10-based, panel B) through the intraerythrocytic cell cycle is accelerated by about
4 to 8 h in comparison with wild-type 3D7 and D10. Scale bars: 5 lm.
doi:10.1371/journal.ppat.0030189.g004
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Lipoic acid metabolism in apicomplexan parasites is
distributed between mitochondrion and apicoplast [11,12].
Both organelles lipoylate their KADHs independently, with
de novo biosynthesis conﬁned to the apicoplast and salvage
solely found in the mitochondrion of the parasite [13–15].
Given this background it was surprising that the LipB gene,
which encodes the principal LA protein ligase in the
apicoplast, can be disrupted without negatively affecting P.
Figure 5. Effect of LipB Disruption on Lipoic Acid Levels and PDH-E2 Lipoylation
(A) WT 3D7 and LipBKO mutants were analysed for their LA content. The data shown were determined in two independent experiments and each
sample was measured in triplicate. Wild-type LA levels are around 40 nmoles/10
8 cells, whereas LipBKO lines had drastically reduced LA levels between
0.9 nmoles/10
8 cells and 2.5 nmoles/10
8 cells.
(B) WT 3D7 and LipBKO2–2 mutant were analysed for their fatty acid content. Fatty acids released by acid and base treatment were converted to methyl
esters and analysed by GC-MS (see Materials and Methods for details). The figure shows an enlargement of the total ion current (TIC) chromatogram
between 25.0 min and 30.0 min in which the fatty acids, including the internal standard (C17:0) at 28.5 min, C14:0 at 25.2 min, C16:1 at 27.3 min, C16:0
at 27.5 min, C18:2, C18:1, and C18:0, as well as the short chain octanoic acid derived LA (oxidised) at 26.4 min, and LA (reduced) at 27.2 min are marked.
The levels of myristic acid (C14:0) clearly increase in the LipBKO line in comparison to wild-type parasites.
(C) Analysis of lipoylation pattern of WT 3D7 and LipBKO mutants. Parasite extracts (15 lg) were separated on 4%–12% SDS-PAGE, blotted to
nitrocellulose, and subsequently were probed with a rabbit anti-LA antibody as described in Materials and Methods. Lane 1, 3D7 wild-type; lane 2,
LipBKO2–1; lane 3, LipBKO2–2. The bands correspond to PDH-E2 (75 kDa), BCDH-E2 (50 kDa), and KGDH-E2 (47 kDa). PDH-E2 lipoylation is greatly
reduced in the mutant lines in comparison with wild-type, showing that the decrease in LA levels is primarily due to loss of the cofactor from the
apicoplast PDH-E2-subunit. The blot was reprobed with an antibody directed against the 22 kDa 2-Cys peroxiredoxin PfTrx-Px1 as a loading control (Trx-
Px1).
doi:10.1371/journal.ppat.0030189.g005
Table 1. Lipoic Acid Levels in Wild-Type and LipBKO P. falciparum
LA Fraction WT LipBKO1–1 LipBKO1–2 LipBKO2–1 LipBKO2–2
LA
(nmol/10
8
Cells)
Percent of
Total LA
LA
(nmol/10
8
Cells)
Percent of
Total LA
LA
(nmol/10
8
Cells)
Percent of
Total LA
LA
(nmol/10
8
Cells)
Percent of
Total LA
LA
(nmol/10
8
Cells)
Percent of
Total LA
Total LA (n ¼ 6) 39.76 6 0.35 100% 1.05 6 0.13 100% 2.18 6 0.04 100% 0.68 6 0.19 100% 3.48 6 1.60 100%
Oxidized LA (n ¼ 3) 30.2 6 1.67 77% 0.54 6 0.19 55% 1.49 6 0.23 70% 0.41 6 0.18 82% 1.30 6 0.17 70%
Reduced LA (n ¼ 3) 9.08 6 0.82 23% 0.43 6 0.19 45% 0.63 6 0.21 30% 0.09 6 0.08 18% 0.56 6 0.23 30%
doi:10.1371/journal.ppat.0030189.t001
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Lipoic Acid Protein Ligases of Plasmodiumfalciparum growth. This was entirely unexpected because it was
thought that LipB activity is absolutely required for the
parasites to lipoylate PDH-E2, which in turn is necessary to
provide acetyl-CoA for fatty acid biosynthesis operating in
the organelle [22]. In fact, down regulation of ACP expression
using a Tet-inducible conditional knockout system in T. gondii
revealed that one major function of apicoplast located type II
fatty acid biosynthesis is to provide octanoyl-ACP for the
lipoylation of PDH-E2 in these related parasites [15]. These
data indirectly suggest that salvage of LA and its subsequent
ligation to the PDH-E2 is not an alternative for the apicoplast
located LA de novo biosynthesis pathway in Toxoplasma. This
is in agreement with data on bacterial LipB, which does not
accept free LA as a substrate [6,26]. Thus, even if exogenous
LA would be taken up into the apicoplast of Toxoplasma it
w o u l dr e q u i r et h ep r e s e n c eo faL p l A - l i k ep r o t e i nt o
guarantee ligation of the cofactor to the apo-PDH-E2.
Analyses of a gene identiﬁed in the ToxoDB database
potentially encoding LplA2 (gene locus: 83.m01296) showed
that the identity between the deduced amino acid sequences
of the Toxoplasma and Plasmodium deduced amino acid
sequences was modest, with less than 10% identity. This is
in contrast to potential LplA2 encoding genes in other
Plasmodium species but also other apicomplexans, such as
Theileria, which contain highly conserved orthologues of P.
falciparum LplA2 (similarities between 58% and 37%). In
addition, highly conserved amino acid motifs necessary for
substrate interaction and activation appear to be absent from
the potential T. gondii LplA2 [27–29]. Therefore, it appears
that the lipoylation pathways in Plasmodium and Toxoplasma
differ to some extent.
The LA content of the LipB mutant parasites was analysed
by GC-MS which revealed that the LipB mutants had a drastic
reduction (;90%) of LA compared to wild-type parasites.
Concomitantly, the levels of myristate (C14:0) increased about
5-fold in the mutant parasites compared to wild-type para-
sites, which could potentially have implications such as the
levels of protein lipidations or speciﬁc lipid species in the
mutant parasite lines [30]. Despite the severe loss of LA, the
LipB mutant parasites showed a faster growth phenotype
which was primarily attributable to accelerated progression
through the intraerythrocytic cell cycle. It is conceivable that
the increased availability of endogenously generated myris-
tate changes the acylation state of regulatory proteins and
affects their activity and/or distribution, which potentially
contributes to the observed phenotype. However, these
speculations have to be further substantiated in future
analyses of the LipB mutants. Another aspect is that the loss
of LA has an impact on the parasites’ capacity to defend
themselves against oxidative stress considering that one of the
most discussed roles of LA is its redox activity and its
potential as antioxidant [31,32]. However, the LipB mutants
appear to be unaffected in their susceptibility to exogenous
and endogenous oxidants despite the signiﬁcant loss of LA.
This potentially could be explained by a compensatory
upregulation of alternative antioxidants in these mutant
parasites—a hypothesis that also needs further investigation.
The observed reduction of LA in the parasites also implies
that PDH-E2 lipoylation should be greatly reduced; by using
Figure 6. Effect of Triclosan, tert-Butylhydroperoxide and N-Methylphenazonium Methosulfate on LipB Mutants
The effect of triclosan (an inhibitor of FabI) (A) and two pro-oxidants (tert-butyl hydroperoxide (B) and N-methylphenazonium methosulfate (C) on
parasite growth were analysed as described in Materials and Methods. The IC50 values of wild-type and LipBKO mutants do not differ markedly
suggesting that LA depletion has no effect on fatty acid biosynthesis and response to pro-oxidants. All three figures show means 6 standard errors of
three independent experiments.
doi:10.1371/journal.ppat.0030189.g006
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The reduced lipoylation appears to not negatively affect de
novo fatty acid biosynthesis as shown by the fatty acid
analyses data (reduction of LA biosynthesis leads to increased
levels of longer chain fatty acids). In addition, mutant and
parent parasite lines showed similar susceptibilities to the
supposed FabI inhibitor triclosan [21]. This shows that the
reduction of PDH-E2 lipoylation does not affect PDH activity
as severely as originally believed and that the multienzyme
complex still provides sufﬁcient acetyl-CoA to sustain fatty
acid biosynthesis. Previous studies on E. coli PDH showed that
the loss of one or two of the three lipoyl-domains of the
bacterial PDH-E2 subunit does not cause signiﬁcant changes
in PDH activity demonstrating that under-lipoylation does
not necessarily yield a catalytically incompetent PDH com-
plex [33].
The fact that PDH-E2 is at all lipoylated is surprising given
that LipB was thought to be the principal LA protein ligase
present in the apicoplast. However, we have shown in this
study that an alternative pathway that allows lipoylation of
PDH-E2 is provided by LplA2, a second LA protein ligase like
protein, identiﬁed in the genome of several Plasmodium
species [14] and a number of other apicomplexan parasites.
However, Toxoplasma appears to lack a LplA2 orthologue—a
gene potentially encoding LplA2 lacks amino acid motifs
essential for a functional LplA protein. The functionality of
Plasmodium LplA2 was corroborated in this study and it was
shown that different expression constructs complement the
growth defect of bacteria deﬁcient in LipB and LipB/LplA,
supporting that the protein compensates for both LplA and
LipB in this bacterial expression system. This is in contrast to
the ﬁndings of [14] who suggested that LplA2 can replace
mitochondrial LplA1 only, and not LipB. However, the
expression constructs used in the previous study differ
considerably from the ones used in this study, which might
explain these different results. Furthermore, it needs to be
emphasised that LplA2 seems to be less efﬁcient in using
octanoyl-ACP as a substrate to lipoylate the PDH-E2 subunit
as shown by the large loss of total LA and the under-
lipoylation of PDH-E2. This clearly suggests that the substrate
speciﬁcities of LipB and LplA2 might differ and studies to
fully characterise LplA2 biochemically and its precise role for
parasite survival are currently underway. The difference in
substrate speciﬁcity between LipB and LplAs is, however, not
very surprising and has been previously shown for the
bacterial enzymes [6]. In fact, overexpression of LipB in E.
coli render them insensitive towards selenolipoic acid,
suggesting that LipB cannot use exogenously supplied LA
or its derivatives as substrates [6,26].
The localisation of LplA2 cannot be reliably predicted and
therefore the full-length protein C-terminally tagged with
GFP was expressed in the erythrocytic stages of P. falciparum.
The results that we obtained were intriguing because the GFP
ﬂuorescence was observed in both the mitochondrion and a
Figure 7. LplA2 Functional Complementation of LipB and LplA/LipB Deficient E. coli
The functionality of LplA2 was analysed by complementing two bacterial lines with three different expression constructs as described in Materials and
Methods. (A) Growth of KER 184 in the presence and absence of LplA2 expression constructs as described in Materials and Methods. Key: 1, pASK-IBA3-
LplA2fl; 2, pASK-IBA3-LplA2-S1; 3, pASK-IBA3-LplA2-S2; 4, pASK-IBA3-LplA1; 5, pASK-IBA3; 6, untransformed (B) Growth of TM 136 in the presence of
LplA1 and LplA2 expression constructs. Key: 1, pASK-IBA3-LplA2fl; 2, pASK-IBA3-LplA2-S1; 3, pASK-IBA3-LplA2-S2; 4, pASK-IBA3-LplA1.
doi:10.1371/journal.ppat.0030189.g007
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The localisation of LplA2 cannot be predicted and therefore it was analysed by localising a C-terminally GFP-tagged protein in P. falciparum erythrocytic
stages. Expression of the GFP-tagged protein in P. falciparum 3D7 was analysed by fluorescence light microscopy. The parasites were costained with
Mitotracker
TM Ros (Molecular Probes) to assess whether LplA2-GFP colocalises with the parasite’s mitochondrion. In panel 1 LplA2 is clearly colocalising
with the mitochondrion. However, as is obvious from panel 2 LplA2-GFP localised also to an organelle close to the mitochondrion but clearly distinct
from it. In panel 3 LplA2-GFP colocalises with the mitochondrion but also is present in a second organelle closely associated with the mitochondrion.
Scale bars: 5 lm.
doi:10.1371/journal.ppat.0030189.g008
Figure 9. Localisation of LplA2 by Immunofluorescence Studies
Immunofluorescent analyses were performed on P. falciparum 3D7 using anti-LplA2 and anti-aLipDH (aE3) antibodies (specifically staining the
apicoplast of the parasites) as outlined in the Materials and Methods section. The data suggest a similar distribution of LplA2 as that shown by
expressing a C-terminally tagged LplA2-GFP construct in the parasites. Panel 1 shows staining of an organelle distinct from the apicoplast, probably
being the mitochondrion. Panel 2 shows costaining of both antibodies, suggesting LplA2 is located in the apicoplast, and panel 3 shows staining of
both the apicoplast and potentially the mitochondrion. Scale bars: 5 lm.
doi:10.1371/journal.ppat.0030189.g009
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order to exclude that these results were attributable to the
over expression of the LplA2-GFP-fusion protein we also
performed immunoﬂuorescence studies on wild-type para-
sites. The anti-LplA2 antibody used detected a protein that
either colocalised with an apicoplast marker (aLipDH), was
closely associated with the apicoplast marker, or was observed
in both organelles. This implies that LplA2 is dually targeted
to mitochondrion and apicoplast supporting the hypothesis
that the loss of LipB functionality can be compensated by
LplA2. Dual targeting has been shown previously in P.
falciparum for the metalloprotease falcilysin [34] and potential
mechanisms by which this is achieved or governed have been
discussed by Ralph [35]. In organisms that contain plastid and
mitochondrion dual targeting is not unusual, particularly for
those proteins involved in biological processes that are found
in both organelles [36,37]. Most proteins targeted to the two
organelles are nuclear-encoded and they possess certain
targeting signals that are not always predictable using
bioinformatics approaches [38]. It has been suggested that
not only the primary amino acid sequence of a protein is
involved in the control of dual targeting but that also
untranslated regions of the mRNA play a role in the process
[37,39]. In apicomplexan parasites the posttranslational
trafﬁcking of apicoplast and mitochondrial proteins differs
considerably from those in plants—mitochondrial proteins
are delivered via the cytosol to their destination whereas the
apicoplast targeting is through the secretory pathway [40].
Therefore it has to be assumed that speciﬁc mechanisms allow
for dual targeting of apicomplexan proteins to both
organelles. Recently, a study by Pino and colleagues showed
that the nature of the signal peptide affects targeting of a
number of unrelated proteins to both mitochondrion and
apicoplast in T. gondii [41]. It is well possible that similar
mechanisms occur in Plasmodium and the fact that lipoylation
is an essential process in both organelles might be the reason
for the dual targeting of LplA2 that we observed in this study.
Overall, this study shows that redundancies exist between
LA protein ligases in the malaria parasite P. falciparum, which
appear to be achievable through dual targeting of LplA2. The
accelerated progression through the cell cycle during intra-
erythrocytic growth of LipB mutants implies that the lack of
LA and LipB is affecting cell cycle control mechanisms.
Future studies will elucidate the underlying reasons for the
rapid progression through the intraerythrocytic cycle and
analyse whether there are growth and developmental impair-
ments during other life cycle stages of the LipB mutant
parasites.
Materials and Methods
Materials. Albumax II and RPMI 1640 were obtained from
Invitrogen Corporation, UK. Irgasan (triclosan), tert-butylhydroper-
oxide and N-methylphenazonium methosulfate were purchased from
Sigma-Aldrich, UK. The Immobilon
TM Western Chemiluminescent
HRP Substrate was obtained from Millipore, UK. Anti-LA rabbit
polyclonal antibody was supplied by Calbiochem and the anti-rabbit
IgG (HþL), HRP conjugate was from Promega. [a-
32P]-ATP (Adeno-
sine 59-triphosphate [a-
32P], EasyTides, speciﬁc activity: 3,000 Ci/
mmol) was purchased from Perkin-Elmer. [8-
3H]-hypoxanthine
(speciﬁc activity: 10–30 Ci/mmol) was from GE Healthcare, UK. All
restriction enzymes were obtained from New England Biolabs.
WR99210 was generously provided by Dr Jacobus, Jacobus Pharma-
ceuticals, USA. The vector pASK-IBA3 was purchased from Institut
fu ¨r Bioanalytik, Germany. The LipB-deﬁcient (KER 184) and LipB/
LplA deﬁcient (TM136) bacterial strains were a kind gift from Dr John
Cronan (University of Illinois at Urbana-Champaign, USA). Plasmids
pHH1andpCDH3/4,PfHSP8659-pDONR4/1,andPfCRT59-pDONR4/1
were kind gifts from Professor A. F. Cowman (The Walter and Eliza
Hall Institute for Medical Research, Melbourne, Australia) and
Professor G. I. McFadden (University of Melbourne, Australia),
respectively.
Knockout and expression constructs of P. falciparum LipB. The
expression and knockout fragments of the P. falciparum LipB gene
were ampliﬁed from P. falciparum 3D7 and D10 genomic DNA using
Pfx Supermix (Invitrogen). The speciﬁc oligonucleotide primers 59-
GCGCAGATCTAATAAAATAAACCTGCTTGTAC-39 (sense) and 59-
GCGCCTCGAG(TTA)TTTATCCTTATAAAAGATACC-39 (antisense)
with the BglII and XhoI restriction sites, respectively, in bold, and an
artiﬁcial stop codon (in brackets) within the antisense oligonucleo-
tide, were used to generate the 999 bp insert equivalent to
nucleotides 4–1,002 of the PfLipB open reading frame for the
PfLipBKO1 construct. The PCR product was subcloned into the
TOPO-Blunt PCR cloning vector (Invitrogen) and its sequence was
veriﬁed (The Sequencing Service, University of Dundee, UK, http://
www.dnaseq.co.uk/) before it was cloned into the P. falciparum
transfection plasmid pHH1 [19]. The second construct comprises
nucleotides 304–1,002 of the open reading frame missing the
potential bipartite targeting sequence. The insert for PfLipBKO2
was ampliﬁed using the sense primer 59-GCGCAGATCTATTAT-
GAAAAATAAAAATGAAGTACAAATATCAAATCATTTAG-39 and
the same antisense primer as for PfLipBKO1. The 699 bp product
was subcloned into TOPO-Blunt as described above for sequence
veriﬁcation before being cloned into pHH1.
Parasite culture, transfection, determination of IC50, and parasite
growth rate. P. falciparum 3D7 (The Netherlands) and P. falciparum D10
(Papua New Guinea) were cultured according to Trager and Jensen
[42] with modiﬁcations in human erythrocytes, RPMI 1640 containing
11 mM glucose, with the addition of 0.5% Albumax II. The parasites
were maintained under an atmosphere of reduced oxygen (1%
oxygen, 3% CO2, and 96% nitrogen) at 37 8C. Parasites were
synchronised using sorbitol according to Lambros and Vanderberg
[43].
Transfection of PfLipBKO1-pHH1, PfLipBKO2-pHH1, HSP86-
LplA2-GFP-pCHDR, and CRT-LplA2-GFP-pCHDR into P. falciparum
erythrocytic stages was performed as described previously [44,45].
WR99210 resistant parasites appeared between 40 and 60 days after
transfection. Parasites were cloned by limiting dilution according to
Kirkman et al. [46].
The effect of triclosan, N-methylphenazonium methosulfate, and
tert-butylhydroperoxide on P. falciparum erythrocytic stages was
determined by measuring the incorporation of [
3H]-hypoxanthine
in the presence of increasing drug concentrations (0.5 lM to 100 lM)
according to [47].
Relative parasite growth rates were determined using the method
of Sanders et al. [21]. Parasite cultures containing mainly ring stages
were synchronised twice within 4 h using sorbitol [43]. Parasite
density was determined and the culture was diluted to 0.5%
parasitaemia, 5% haematocrit. Cultures were maintained under an
atmosphere of reduced oxygen at 37 8C and medium was refreshed
every 24 h. Cultures were diluted 5-fold at 48 h intervals and growth
was monitored by Giemsa-stained thin blood smears every 24 h. For
each determination of percentage parasitaemia the number of
infected erythrocytes per 1,000 erythrocytes was recorded.
Concentration of trophozoite-infected erythrocytes using MACS
columns. Cultured parasites were enriched for late-stage forms by
using the VarioMACS separator and CS MACS columns (Miltenyi
Biotec). The columns were equilibrated with MACS buffer (PBS
supplemented with 0.5% (w/v) BSA, 2mM EDTA) for 5 min and rinsed
with 60 ml of MACS buffer. The equivalent of 100 ml cultured P.
falciparum was resuspended in MACS buffer and applied to the
column. Following ﬂow-through of the cell-suspension, the column
was washed with 50 ml MACS buffer. The column was then removed
from the magnetic ﬁeld of the VarioMACS separator and the late-
stage parasitised erythrocytes were eluted from the column using 30
ml MACS buffer. The suspension was centrifuged and the cells were
resuspended in complete medium and returned to culture conditions
for 30 min prior to harvesting by saponin lysis. The typical yield from
this procedure was 1–2 3 108 isolated late-stage parasites.
Preparation of genomic DNA and protein from P. falciparum. The
parasites were liberated from erythrocytes by saponin lysis [48] and
genomic DNA was isolated using the QIAamp DNA Mini Kit (Qiagen).
Protein extracts were prepared from saponin-isolated parasites by
resuspending the pellets in lysis buffer (100 mM HEPES (pH 7.4), 5
mM MgCl2, 10 mM EDTA, 0.5% (v/v) TritonX-100, 5 lg/ml RNAse, 1
mM phenylmethylsulphonyl ﬂuoride, 1 mM benzamidine, 2 lg/ml
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followed by three cycles of freeze/thawing and sonication in a
sonicating water-bath (Fisherbrand). Protein concentrations were
determined using the Bradford assay [49].
Southern blot analyses. One lg of genomic DNA was digested with
NdeI, separated on a 0.8% agarose gel, and blotted onto positively
charged nylon membrane (GE Healthcare) using standard methods
[50]. The blot was probed with the LipB coding sequence. Radioactive
probes were made using the MegaPrime Labelling Kit from GE
Biosciences and [a-
32P]-ATP (Adenosine 59-triphosphate [a-
32P],
EasyTides, Speciﬁc Activity: 3,000 Ci/mMole) from Perkin-Elmer
following the manufacturer’s recommendations. The membrane was
prehybridised (0.5% (w/v) SDS, 5 3 Denhardt’s solution, 100 lg/ml
salmon sperm DNA, 0.1% (w/v) sodium pyrophosphate) for 2 h at 60
8C before addition of the probe. Hybridisation was then allowed to
proceed at 60 8C over night. Membranes were washed once in 63SSC,
0.1% (w/v) SDS at 60 8C for 20 min, and then twice in 23SSC, 0.1% (w/
v) SDS at 60 8C for 10 min. Membranes were exposed to Kodak ﬁlm
for several days before development depending on the activity of the
probe used.
Western blot analyses. To determine lipoylation of KADH-E2
subunits in P. falciparum, protein extracts of parasites were subjected
to Western blotting. Brieﬂy, 15 lg of each sample was separated on a
4%-12% SDS-PAGE (Invitrogen) and then blotted onto nitrocellulose
(Schleicher and Schu ¨ll), using standard techniques [50]. The blot was
incubated with a rabbit anti-LA antibody (Calbiochem) at a dilution
of 1:500 and the secondary anti-rabbit IgG (HþL), HRP conjugate
(Promega) at a dilution of 1:10,000 before being developed using the
Immobilon
TM Western Chemiluminescent HRP Substrate (Millipore).
Similarly, blots of wild-type parasite extracts were also probed with
antibodies against BCDH-E2 (raised in rabbit), KGDH-E2 (raised in
rat) and H-protein (raised in rabbit) of P. falciparum (all generated by
Eurogentec, Belgium) at dilutions of 1:5,000, 1:100 and 1:2,000,
respectively.
Quantitation of lipoic acid by gas-chromatography mass-spectrom-
etry. Samples for LA analyses were prepared from late trophozoites
prepared using the MACS columns described above. The LA
detection method was modiﬁed from that of Pratt and colleagues
[51]. LA determinations were done in triplicate, along with a parallel
control of standards, all containing an internal standard of
heptadecanoic acid (10 nmol). Experimental details for the determi-
nation of LA will be published elsewhere (T. K. Smith, in
preparation). Brieﬂy, total LA was determined by acid hydrolysis of
freeze-dried parasite pellets to release protein bound fatty acids.
Reduction with NaBH4 and methylation with methyl iodide of the
sulphydryl groups under basic conditions was followed by organic
extraction of all fatty acids, including the methylated LA. The dried
fatty acids were converted to fatty acid methyl esters (FAME) with
diazomethane and stored dried at  20 8C until subjected to GC-MS.
Quantiﬁcation of oxidised LA was as above except no reduction or
methylation of the sulphydryl groups is required. Free LA was
extracted from a freeze-dried cell pellet with organic solvents which
were checked for protein by analysis of SDS-PAGE and staining, prior
to treatment with methanolic HCl and conversion to fatty acid
methyl esters as above.
Analysis of the FAMEs was conducted on a Hewlett Packward 6890–
5973 system equipped with a ZB-5 30M30.25 mm (I.D.) column. The
electron impact ionization/quadrupole mass detector was pro-
grammed to monitor selected ions for all FAMEs m/z 123, heptade-
canoic acid m/z 284, oxidised LA m/z 220, reduced and methylated m/z
250, with typical elution times of oxidised LA, 26.4 min; reduced and
methylated LA, 27.2 min; and heptadeconic acid (C17:0), 28.5 min.
Molar response factor for oxidised LA and methylated reduced LA
versus heptadecanoic acid were determined to estimate the LA
content. In addition, the total ion current (TIC) chromatograms were
analysed for changes in other longer chain fatty acids.
Complementation of LipB and LipB/LplA-deﬁcient E. coli by LplA2.
The functionality of three expression constructs of LplA2, generated
in pASK-IBA3, was analysed. The following anti-sense primer 59-
GCGCGCGGTCTCAGCGCTTAGAAAATATGTTGGTATATCGTAA-
TACC-39 was used to amplify all three constructs. In combination
with the sense primer 59-GCGCGCGGTCTCGAATGAGAATTA-
TAAAGTGCCTGGATC-39 a 1,152 bp fragment was ampliﬁed
corresponding to the full length gene. The sense primer 59-
GCGCGCGGTCTCGAATGAAAAAAATAAACATTCTTTATTT-
TATTGATGTCAGC-39 generated a truncated fragment from nucleo-
tide 79–1,152 (S1 construct). The third fragment (S2) ampliﬁed using
59-GCGCGCGGTCTCGAATGAATGAGTCCAAAGGAAAC-
GAATGC-39 corresponds to nucleotide 235–1,152 bp. All primers
contained a BsaI restriction site (boldface) to allow directional
cloning into pASK-IBA3. The constructs were ampliﬁed from P.
falciparum 3D7 genomic DNA using Pfx Supermix (Invitrogen) and
were initially cloned into TOPO-Blunt PCR cloning vector (Invi-
trogen) for sequence veriﬁcation. Subsequently, they were subcloned
into pASK-IBA3 and transformed into KER 184 and TM 136 [24,25]
to assess whether they complement the growth defect of the bacterial
lines when grown on minimal medium agar plates.
Localisation of LplA2. To analyse the localisation of LplA2, the full
length LplA2 gene was ampliﬁed from P. falciparum 3D7 genomic DNA
using the sense primer 59-CACCATGAGAATTATAAAGTGCCTGG-
39 and antisense primer 59-TAGAAAATATGTTGGTATATCGTAA-
TACC-39. The PCR product was cloned directionally into the plasmid
pENTR/D-TOPO (Invitrogen) and the sequence was veriﬁed by
sequencing. The cloning of the constructs was performed as
described by van Dooren et al. [52]. The destination plasmid used
was pCHDR-3/4 which contains the human dihydrofolate reductase
(hDHFR) as a selectable marker. Two entry plasmids were used that
differed in their promoter regions. The PfHsp86 59-pDONR4/1
contains the P. falciparum heat shock protein 86 59 UTR and the
PfCRT 59-pDONR4/1 possesses the P. falciparum chloroquine resist-
ance transporter 59UTR. The C-terminal GFP-tag was provided by
GFP-pENTR2/3. Thus, four plasmids (either PfHspP86-pENTR4/1 or
PfCRT-pENTR4/1, LplA2-pENTR/D-TOPO, GFP-pENTR2/3, and
pCHDR-3/4) were incubated in the LR MultiSite cloning reaction
according to manufactures guidelines (Invitrogen) which resulted in
the generation of two LplA2 constructs (Hsp86-LplA2-GFP-pCHDR
and CRT-LplA2-GFP-pCHDR). Constructs were transfected as de-
scribed above and parasites resistant to WR99210 were analysed using
an Axioskop-2 mot plus microscope (Zeiss) equipped with a
Hamamatsu C4742–95 CCD camera.
Fixations of wild-type 3D7 parasites for subsequent immunoﬂuor-
escence analyses were carried out according to [53]. The primary
antibodies raised against LplA2 (in a rat, Eurogentec) and against
apicoplast lipoamide dehydrogenase (aLipDH; aE3) (in a rabbit,
Eurogentec) were diluted in 3% (w/v) BSA in PBS at 1:500 and 1:200,
respectively. Secondary antibodies (anti-rat conjugated with Alexa
ﬂuor 488 and anti-rabbit conjugated with Alexa ﬂuor 594, Molecular
Probes) were applied at 1:500 dilution in 3% (w/v) BSA in PBS for 1 h
at 4 8C. DAPI at 0.5 lg/ml (Sigma) was added to the secondary
antibody for 1 min and was then washed off as before. The slides were
mounted with 2.5% (v/v) DAPCO in 50% (v/v) glycerol (Sigma) and
were analysed using an Axioskop-2 mot plus microscope (Zeiss)
equipped with a Hamamatsu C4742–95 CCD camera.
Supporting Information
Accession Numbers
The accession numbers and ID numbers of the genes (obtained from
the NCBI-protein database) described in this study are as follows: Bos
taurus lipoate-activating enzyme (BAB40420), Bos taurus lipoyltrans-
ferase (BAA24354), E. coli (K12) LplA (NP_418803), E. coli (K12) LipB
(NP_415163), P. berghei LplA2 (XP_679932; CAH95194), P. chabaudi
LplA2 (XP_745010; CAH79244), P. falciparum ACP (XP_001349595;
AAC71866), P. falciparum apicoplast lipoamide dehydrogenase
(XP_001349365; CAD51214), P. falciparum BCDH-E2
(XP_001351112; CAB38991), P. falciparum enoyl-ACP reductase
(FabI) (XP_966137; CAG25389), P. falciparum H-protein
(XP_001348010; AAN35923), P. falciparum KGDH-E2
(XP_001349947; CAD52355), P. falciparum LipA (XP_001350160;
CAD52569), P. falciparum LipB (XP_001349288; CAD51137), P.
falciparum LplA1 (XP_001349882; CAD52290), P. falciparum LplA2
(XP_001352107; CAD51918), P. falciparum PDH-E2 (XP_001347486;
AAN35399), P. knowlesi LplA2 (gene ID PlasmoDB: PKH_072080), P.
vivax LplA2 (PlasmoDB gene ID: Pv099590), P. yoelii LplA2
(XP_730272 ; EAA21837), Theileria parva strain Ankara LplA2
(XP_954802), T. gondii ACP (AAC63956; AAC63953), T. gondii LplA2
(ToxoDB gene ID 83.m01296).
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